VICTOZA 2 PEN

Sku: 24071
60.140 KD
Size: 2 PEN

In stock


VICTOZA® PROVIDED AN ADDITIONAL BENEFIT OF GREATER WEIGHT LOSS IN 2 HEAD-TO-HEAD TRIALS





Victoza® is not indicated for chronic weight management, and weight change was a secondary endpoint in clinical trials.



OR
Description

Details

Victoza® (liraglutide) injection 1.2 mg or 1.8 mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, and to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes mellitus and established CV disease
Additional Information

Additional Information

Brands

No

Size

2 PEN

Is Featured

No

Directions of use

Once a day, at any time, independent of meals. Victoza® does not require resuspension and can be injected in the abdomen, thigh, or upper arm with the NovoFine®

Active Ingredients

liraglutide

Indication

Victoza® (liraglutide) injection 1.2 mg or 1.8 mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, and to reduce the risk of major adverse cardiovascular (CV) events (

Skin Type

No

Reviews
Login/Sing-up to add a review